Health Care: Drugs

Nektar Therapeutics Inc (NKTR: NASDAQ)

$11.17 n/a | n/a%
10/02/15 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 11.17
52 Week High 17.53
52 Week Low 9.16
Avg. Daily Vol. (Mil) 1.40
Beta (3 year) 1.02
Share Related Items
Mkt Cap (Mil) 1,478.58
Shares Out (Mil) 132.37
Float (Mil) 87.75
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.20
Current Ratio 3.70
LT Debt/ Equity 3.64
Total Debt / Equity 3.80
Valuation Ratios
Price Earnings 469.00
Price/Sales 5.21
Price/Book 42.13
Price/Cash Flow 80.70
Per Share Data
Earnings 0.02
Sales 2.14
Book Value 0.27
Cash Flow 0.14
Business Summary
Nektar Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops a pipeline of drug candidates that utilizes its PEGylation and polymer conjugate technology platforms that are designed to developmolecular entities.
General Information
455 Mission Bay Boulevard So
San Francisco, CA 94158
Industry : Drugs
Sector: Health Care
Employees: 438
CEO: Mr. Howard W. Robin
Short Interest
Current Month (Mil) 22.24
Previous Month (Mil) 21.57
Short Interest Ratio (Days) 17.20
Management Effectiveness
Return on Equity 17.30
Return on Assets 1.30
Return on Investments 3.70
Gross Margin 92.20
EBIT Margin 15.20
Profit Margin 2.10

Portfolios with NKTR

Latest NKTR Headlines from TheStreet

More Financial News for NKTR

Press Releases for NKTR

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter